Expression of interleukin 15 in primary adult acute lymphoblastic leukemia

Cancer

Volumn 116, Issue 2, 2010, Pages 387-392

  Wu, Shuling ^a   Fischer, Lars ^a   Gökbuget, Nicola ^b   Schwartz, Stefan ^a   Burmeister, Thomas ^a   Notter, Michael ^a   Hoelzer, Dieter ^b   Fuchs, Hendrik ^a   Blau, Igor Wolfgang ^a   Hofmann, Wolf K ^a   Thiel, Eckhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Acute lymphoblastic leukemia; IL 15 expression; Organ infiltration; Prognosis

Indexed keywords

BCR ABL PROTEIN; INTERLEUKIN 15; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER INFILTRATION; CANCER SURVIVAL; CELL LINEAGE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; CYTOKINE PRODUCTION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC RISK; HEPATOMEGALY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; LEUKEMIA RELAPSE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; OVERALL SURVIVAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLENOMEGALY; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-15; KARYOTYPING; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 75649131519     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24729     Document Type: Article

References (24)

1. Fielding AK, Richards SM, Chopra R, et al. Outcome of 609 adults after relapse of acutelymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2007;109:944-950.
2. Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic Leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/ maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ ECOG E2993). Blood. 2008;111:1827-1833.
3. Fehniger TA, Caligiuri MA, Interleukin 15: Biology and relevance to human disease. Blood. 2001;97:14-32.
4. Wu S, Gessner R, von Stackelberg A, Kirchner R, et al. Cytokine/ cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. Cancer. 2005; 103:1054-1063.
5. Ma A, Koka R, Burkett P. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol. 2006;24:657-679.
6. Lodolce JP, Burkett PR, Koka RM, et al. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Growth Factor Rev. 2002;13:429-439.
7. Giron-Michel J, Giuliani M, Fogli M, et al. Membrane-bound and soluble IL-15/IL-15Ralpha complexes display differential signaling and functions on human hematopoietic progenitors. Blood. 2005;106:2302-2310.
8. Trentin L, Cerutti A, Zambello R, et al. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood. 1996;87: 3327-3335.
9. Tinhofer I, Marschitz I, Henn T, et al. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood. 2000;95:610-618.
10. Cario G, Izraeli S, Teichert A, et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol. 2007; 25:4813-4820.
11. Budagian V, Bulanova E, Paus R, et al. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17:259-280.
12. Blaser BW, Roychowdhury S, Kim DJ, et al. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood. 2005;105:894-901.
13. VanBuskirk AM, Pidwell DJ, Adams PW, et al. Transplantation immunology. JAMA. 1997;278:1993-1999.
14. Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. 2006:133-141.
15. Wu S, Korte A, Kebelmann-Betzing C, et al. Interaction of bone marrow stromal cells with lymphoblasts and effects of predinsolone on cytokine expression. Leuk Res. 2005;29:63-72.
16. Beillard E, Pallisgaard N, van der Velden VHJ, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using "real-time" quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia. 2003;17:2474-2486.
17. Bulfone-Paus S, Bulanova E, Budagian V, et al. The interleukin-15/ interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays. 2006;28:362-377.
18. Huettner CS, Zhang P, Van Etten RA, et al. Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet. 2000;24:57-60.
19. Dubois S, Mariner J, Waldmann TA, et al. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity. 2002;17:537-547.
20. Budagian V, Bulanova E, Orinska Z, et al. Reverse signaling through membrane-bound interleukin-15. J Biol Chem. 2004;279:42192-42201.
21. Maurer J, Janssen JW, Thiel E, et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet. 1991;337:1055-1058.
22. Gleissner B, Gokbuget N, Bartram CR, et al. German Multicenter Trials of Adult Acute Lymphoblastic Leukemia Study Group. Leading prognostic relevance of the BCRABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis. Blood. 2002;99:1536-1543.
23. Lin TS, Mahajan S, Frank DA. STAT signaling in the pathogenesis and treatment of leukemias. Oncogene. 2000; 19:2496-2504.
24. Kobayashi H, Dubois S, Sato N, et al. Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood. 2005;105:721-727.